Skip to content

The Effectiveness of the Wim Hof Method in People with Spinal Cord Injury

The Effectiveness of the Wim Hof Method on Physical and Mental Health of People with a Spinal Cord Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05704322
Enrollment
60
Registered
2023-01-30
Start date
2023-03-27
Completion date
2024-12-01
Last updated
2024-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

People with a spinal cord injury (SCI) often experience secondary medical complications. One of the methods that may help to prevent or deal with secondary complications in people with SCI is the Wim Hof Method (WHM). The WHM is based on three elements: 1) breathing exercises, 2) gradual cold exposure (cold showers, or cold water immersion), and 3) mindset. The primary objective of this randomized controlled trial is to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure), on health-related quality of life in people with SCI. The secondary objectives are to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure) in people with SCI on: inflammation markers, metabolic health, pulmonary function, body composition, sleep quality, spasticity, stress, and on chronic pain.

Detailed description

A spinal cord injury (SCI) is a serious medical condition that causes functional, psychological and socioeconomic disorder. Long-term, secondary medical complications are common and play an important role in the continuum of care for people with SCI. Complications are a frequent cause of morbidity and mortality and lead to increased rates of rehospitalisation, loss of employability and decreased quality of life. During multidisciplinary SCI rehabilitation, the treatment is focussed on working with the patient physically and psychologically to maximize their neurological recovery and general health but also to prevent or deal with the secondary complications. One of the methods that may help to prevent or deal with secondary complications in people with SCI is the Wim Hof Method (WHM). The WHM is based on three elements: 1) breathing exercises, 2) gradual cold exposure (cold showers, or cold water immersion), and 3) mindset. Previous studies showed a positive effect of the WHM on health-related quality of life and the inflammatory profile of healthy individuals as well as patients with active axial spondyloarthritis. Furthermore, a pilot study in people with SCI showed that the WHM (only breathing exercises and mindset) led to positive changes in respiratory function, mental health index, hyperventilation and a trend was visible regarding the hindrance due to spasticity. Some of the participants mentioned that they experienced positive effects on coughing, energy level, mood or used less spasticity medication after the WHM intervention. These positive findings in the pilot study warrant a full-scale randomised-controlled trial (RCT) of this novel therapeutic approach in people with SCI. The primary objective of this randomized controlled trial is to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure), on health-related quality of life in people with SCI. The secondary objectives are to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure) in people with SCI on: inflammation markers, metabolic health, pulmonary function, body composition, sleep quality, spasticity, stress, and on chronic pain.

Interventions

OTHERWim Hof Methode

The intervention groups will follow a 7-weeks intervention, with one practice session per week at the rehabilitation center led by Wim Hof or one of his instructors. Besides these joint weekly sessions, the intervention groups have to practice daily at home with the Wim Hof Method app.

Sponsors

Dr. C.J. Vaillant Fonds
CollaboratorUNKNOWN
W.M. de Hoop Stichting
CollaboratorUNKNOWN
Ars Donandi / Yske Walther fonds
CollaboratorUNKNOWN
Reade foundation
CollaboratorUNKNOWN
Stichting Reade
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Individuals (Male/Female) with either a complete or incomplete chronic SCI. In this study, a chronic SCI is defined as a time since injury ≥ 1 year. * Participants have to be between 18 and 75 years old.

Exclusion criteria

* Cardiac arrhythmias or cardiac disease; * A history of severe autonomic dysreflexia assessed with the 'Autonomic standards assessment'; * Severe pulmonary disease (such as COPD) based on a pulmonary history; * Insufficient mastery of the Dutch language (speaking and reading); * Severe cognitive or communicative disorders; * Progressive disease; * Being or becoming pregnant during the study period; * Severe psychiatric illness or disorders (at the discretion of the treating rehabilitation physician); * Involved in another intervention study which may have an effect on the outcome measures of the present study; * Experience with (parts of) the Wim Hof Method. * Negative advice from physician to participate in the Wim Hof Method intervention based on the medical screening.

Design outcomes

Primary

MeasureTime frameDescription
Change in mental healthAssessed before and after the 7-weeks WHM interventionMental Health Index - 5 (MHI-5), a subscale of the SF-36. The MHI-5 has a score of 0 to 100, where a score of 100 represents optimal mental health.

Secondary

MeasureTime frameDescription
Change in mindful attention awarenessAssessed before and after the 7-weeks WHM interventionThe Mindful Attention Awareness Scale is a 15-item scale designed to assess a core characteristic of mindfulness. Each item can be scored from 1 (almost always) to 6 (almost never). The overall outcome is the average of the 15 items, with a higher score indicating being more mindful.
Change in hyperventilationAssessed before and after the 7-weeks WHM interventionThe Nijmegen Hyperventilation Syndrome Questionnaire has 16 items (related to symptoms of hyperventilation syndrome) to be answered on a 5-point scale ranging from 'never' (0) to 'very often' (4). A total score of more than 23 out of 64 points suggests significant hyperventilation.
Change in pain and pain interferenceAssessed before and after the 7-weeks WHM interventionFour questions of the International Spinal Cord Injury Pain basic data set will be used to assess (the interference of) pain on a 0 (no pain or no interference) to 10 (extreme pain or extreme interference) range.
Change in sleep qualityAssessed before and after the 7-weeks WHM interventionPittsburgh Sleep Quality Index (PSQI) is a self-rating questionnaire resulting in a global score between 0 and 21, which consists of seven subscores. Higher scores indicate worse sleep quality.
Change in hindrance due to spasticityAssessed before and after the 7-weeks WHM interventionHindrance due to spasticity will be assessed with a subjective rating scale for each of the following activities: (1) sleeping; (2) making transfers; (3) washing and clothing; (4) wheelchair driving; (5) 'others'. The scale ranges from 0 to 2 (0: no hindrance due to spasticity; 1: little hindrance due to spasticity; 2: a lot of hindrance due to spasticity). A sum score for hindrance during all activities will be calculated. It ranges from 0 (no hindrance) to 10 (a lot of hindrance during all activities).
Change in CRPAssessed before and after the 7-weeks WHM interventionConcentration CRP (mg/L) in blood
Change in IL-6Assessed before and after the 7-weeks WHM interventionConcentration IL-6 (pg/ml) in blood
Change in fasted glucoseAssessed before and after the 7-weeks WHM interventionConcentration of fasted glucose (mmol/l) in blood
Change in triglyceridesAssessed before and after the 7-weeks WHM interventionConcentration of triglycerides (mmol/l) in blood
Change in high-density lipoproteinAssessed before and after the 7-weeks WHM interventionConcentration of high-density lipoprotein (mmol/l) in blood
Change in health-related quality of lifeAssessed before and after the 7-weeks WHM interventionThe SF-36 measures measures eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each scale is scored on a 0 to 100 range, a higher score defines a more favorable health state.
Change in total cholesterolAssessed before and after the 7-weeks WHM interventionConcentration of total cholesterol (mmol/l) in blood
Change in blood pressureAssessed before and after the 7-weeks WHM interventionSystolic and diastolic blood pressure (mm Hg)
Change in forced vital capacityAssessed before and after the 7-weeks WHM interventionForced vital capacity (FVC, liter) measured by spirometry
Change in forced expiratory volumeAssessed before and after the 7-weeks WHM interventionForced expiratory volume in 1 sec (FEV1, liter) measured by spirometry
Change in forced inspiratory volumeAssessed before and after the 7-weeks WHM interventionForced inspiratory volume in 1 sec (FIV1, liter) measured by spirometry
Change in peak expiratory flowAssessed before and after the 7-weeks WHM interventionPeak expiratory flow (PEF, liter/s) measured by spirometry
Change in peak inspiratory flowAssessed before and after the 7-weeks WHM interventionPeak inspiratory flow (PIF, liter/s) measured by spirometry
Change in body massAssessed before and after the 7-weeks WHM interventionBody mass (kg) measured on a (wheelchair) weighing scale
Change in fat and fat free massAssessed before and after the 7-weeks WHM interventionFat mass and fat free mass (both in kg) measured by bio-impedance analysis:
Participant compliance and experiencesAssessed before and after the 7-weeks WHM interventionDiary and exit interview
Change in low-density lipoproteinAssessed before and after the 7-weeks WHM interventionConcentration of low-density lipoprotein (mmol/l) in blood

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026